GSK-3 as a therapeutic target of lithium

被引：0
|
作者：
Klein, P. S. [1 ]
机构：
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2006年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [1] Lithium and Therapeutic Targeting of GSK-3
    Snitow, Melinda E.
    Bhansali, Rahul S.
    Klein, Peter S.
    CELLS, 2021, 10 (02) : 1 - 24
  • [2] GSK-3β, a Therapeutic Target for Cardiomyocyte Protection
    Miura, Tetsuji
    Miki, Takayuki
    CIRCULATION JOURNAL, 2009, 73 (07) : 1184 - 1192
  • [3] The GSK-3 Family as Therapeutic Target for Myocardial Diseases
    Lal, Hind
    Ahmad, Firdos
    Woodgett, James
    Force, Thomas
    CIRCULATION RESEARCH, 2015, 116 (01) : 138 - 149
  • [4] GSK-3 as potential target for therapeutic irvention in cancer
    McCubrey, James A.
    Steelman, Linda S.
    Bertrand, Fred E.
    Davis, Nicole M.
    Sokolosky, Melissa
    Abrams, Steve L.
    Montalto, Giuseppe
    D'Assoro, Antonino B.
    Libra, Massimo
    Nicoletti, Ferdinando
    Maestro, Roberta
    Basecke, Jorg
    Rakus, Dariusz
    Gizak, Agnieszka
    Demidenko, Zoya
    Cocco, Lucio
    Martelli, Alberto M.
    Cervello, Melchiorre
    ONCOTARGET, 2014, 5 (10) : 2881 - 2911
  • [5] GSK-3 kinase a putative therapeutic target in trypanosomatid parasites
    Diaz, Alfredo Prado
    Canal, Cristian Alejandro Meneses
    Valdes, Alvaro Jose
    Delgado, Jaider Elian Giraldo
    Varela-M, R. E.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2024, 28 (02):
  • [6] Inhibition of GSK-3 by lithium
    Hedgepeth, C
    Conrad, LJ
    Klein, PS
    BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 106S - 106S
  • [7] Glycogen synthase kinase 3 beta (GSK-3β) as a therapeutic target in neuroAIDS
    Dewhurst, Stephen
    Maggirwar, Sanjay B.
    Schifitto, Giovanni
    Gendelman, Howard E.
    Gelbard, Harris A.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2007, 2 (01) : 93 - 96
  • [8] Glycogen Synthase Kinase 3 Beta (GSK-3β) as a Therapeutic Target in NeuroAIDS
    Stephen Dewhurst
    Sanjay B. Maggirwar
    Giovanni Schifitto
    Howard E. Gendelman
    Harris A. Gelbard
    Journal of Neuroimmune Pharmacology, 2007, 2 : 93 - 96
  • [9] GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
    Rowe, Michael K.
    Wiest, Charlotte
    Chuang, De-Maw
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2007, 31 (06): : 920 - 931
  • [10] GSK-3 as a target of lithium action in bipolar disorder and Alzheimer's disease
    O'Brien, WT
    O'Donnell, M
    Phiell, CJ
    Wilson, CA
    Lee, VM
    Woodgett, JR
    Maretto, S
    Piccolo, S
    Klein, PS
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S39 - S39
12345